Loading...

Jordan Stanley C

TitleDirector
InstitutionUniversity of California Los Angeles
DepartmentKidney Transplant Program
Address8700 Beverly Bl
Los Angeles CA 90095
Phone310-855-4747
vCardDownload vCard
    Other Positions
    TitleDirector

    TitleDirector

    TitleDirector

    TitleDirector

    TitleProfessor

    TitleProfessor


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Jordan SC, Ammerman N, Choi J, Huang E, Peng A, Sethi S, Najjar R, Toyoda M, Lim K, Louie S, Vo A. Novel Therapeutic Approaches to Allosensitization and Antibody-Medicated Rejection. Transplantation. 2018 Sep 21. PMID: 30247320.
      View in: PubMed
    2. Jordan SC, Bunnapradist S, Bromberg JS, Langone AJ, Hiller D, Yee JP, Sninsky JJ, Woodward RN, Matas AJ. Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients. Transplant Direct. 2018 Sep; 4(9):e379. PMID: 30234148.
      View in: PubMed
    3. Jordan SC, Choi J, Aubert O, Haas M, Loupy A, Huang E, Peng A, Kim I, Louie S, Ammerman N, Najjar R, Puliyanda D, Vo A. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. Am J Transplant. 2018 Apr 10. PMID: 29637714.
      View in: PubMed
    4. Huang E, Jordan SC. Immunoglobulin G-Degrading Enzyme of Streptococcus pyogenes (IdeS), Desensitization, and the Kidney Allocation System: Complementary Approaches to Increase Transplantation in Highly HLA Sensitized Patients. Clin J Am Soc Nephrol. 2018 May 07; 13(5):799-801. PMID: 29523676.
      View in: PubMed
    5. Steggerda JA, Kim IK, Haas M, Zhang X, Kang A, Pizzo H, Kamil E, Jordan S, Puliyanda D. Clinical and histopathologic features of antibody-mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor-specific antibodies. Pediatr Transplant. 2017 Dec; 21(8). PMID: 29159992.
      View in: PubMed
    6. Zhang H, Huang E, Kahwaji J, Nast CC, Li P, Mirocha J, Thomas DL, Ge S, Vo AA, Jordan SC, Toyoda M. Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated Rejection. Transplantation. 2017 10; 101(10):2419-2428. PMID: 28557957.
      View in: PubMed
    7. Kim I, Wu G, Chai NN, Klein AS, Jordan S. Ibrutinib suppresses alloantibody responses in a mouse model of allosensitization. Transpl Immunol. 2017 Dec; 45:59-64. PMID: 28951258.
      View in: PubMed
    8. Kim IK, Choi J, Vo A, Kang A, Steggerda J, Louie S, Haas M, Mirocha J, Cohen JL, Pizzo H, Kamil ES, Jordan SC, Puliyanda D. Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients. Pediatr Transplant. 2017 Dec; 21(8). PMID: 28929636.
      View in: PubMed
    9. Jordan SC, Lorant T, Choi J, Kjellman C, Winstedt L, Bengtsson M, Zhang X, Eich T, Toyoda M, Eriksson BM, Ge S, Peng A, Järnum S, Wood KJ, Lundgren T, Wennberg L, Bäckman L, Larsson E, Villicana R, Kahwaji J, Louie S, Kang A, Haas M, Nast C, Vo A, Tufveson G. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med. 2017 08 03; 377(5):442-453. PMID: 28767349.
      View in: PubMed
    10. O'Connell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE. Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction. Transplantation. 2017 07; 101(7):1527-1534. PMID: 28207630.
      View in: PubMed
    11. Ge S, Karasyov A, Sinha A, Petrosyan A, Lovato D, Thomas DL, Vo A, Jordan SC, Toyoda M. Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant Patients. Transplantation. 2017 07; 101(7):1720-1726. PMID: 27841845.
      View in: PubMed
    12. Kim IK, Choi J, Vo AA, Kang A, Patel M, Toyoda M, Mirocha J, Kamil ES, Cohen JL, Louie S, Galera O, Jordan SC, Puliyanda DP. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients. Transplantation. 2017 04; 101(4):883-889. PMID: 27495773.
      View in: PubMed
    13. Shin BH, Ge S, Mirocha J, Jordan SC, Toyoda M. Tocilizumab (Anti-IL-6R) Suppressed TNFa Production by Human Monocytes in an In Vitro Model of Anti-HLA Antibody-Induced Antibody-Dependent Cellular Cytotoxicity. Transplant Direct. 2017 Mar; 3(3):e139. PMID: 28361123.
      View in: PubMed
    14. Toyoda M, Shin BH, Ge S, Mirocha J, Thomas D, Chu M, Rodriguez E, Chao C, Petrosyan A, Galera OA, Vo A, Choi J, Peng A, Kahwaji J, Jordan SC. Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients. J Immunol Res. 2017; 2017:5672523. PMID: 28265581.
      View in: PubMed
    15. Haas M, Mirocha J, Reinsmoen NL, Vo AA, Choi J, Kahwaji JM, Peng A, Villicana R, Jordan SC. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies. Kidney Int. 2017 03; 91(3):729-737. PMID: 28104301.
      View in: PubMed
    16. Sethi S, Choi J, Toyoda M, Vo A, Peng A, Jordan SC. Desensitization: Overcoming the Immunologic Barriers to Transplantation. J Immunol Res. 2017; 2017:6804678. PMID: 28127571.
      View in: PubMed
    17. Jordan SC, Choi J, Kim I, Wu G, Toyoda M, Shin B, Vo A. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade. Transplantation. 2017 Jan; 101(1):32-44. PMID: 27547870.
      View in: PubMed
    18. Kahwaji J, Jordan SC, Najjar R, Wongsaroj P, Choi J, Peng A, Villicana R, Vo A. Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab. Transpl Int. 2016 Dec; 29(12):1276-1285. PMID: 27529314.
      View in: PubMed
    19. Kim I, Wu G, Chai NN, Klein AS, Jordan SC. Immunological characterization of de novo and recall alloantibody suppression by CTLA4Ig in a mouse model of allosensitization. Transpl Immunol. 2016 09; 38:84-92. PMID: 27507323.
      View in: PubMed
    20. Jordan SC, Choi J, Kim I, Vo A, Peng A, Kahwaji J. Risk factors associated with the development of histocompatibility leukocyte antigen sensitization. Curr Opin Organ Transplant. 2016 Aug; 21(4):447-52. PMID: 27258577.
      View in: PubMed
    21. Berger M, Baldwin WM, Jordan SC. Potential Roles for C1 Inhibitor in Transplantation. Transplantation. 2016 Jul; 100(7):1415-24. PMID: 26599489.
      View in: PubMed
    22. Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. N Engl J Med. 2016 Mar 10; 374(10):940-50. PMID: 26962729.
      View in: PubMed
    23. Vo AA, Choi J, Kim I, Louie S, Cisneros K, Kahwaji J, Toyoda M, Ge S, Haas M, Puliyanda D, Reinsmoen N, Peng A, Villicana R, Jordan SC. A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients. Transplantation. 2015 Nov; 99(11):2356-63. PMID: 26018350.
      View in: PubMed
    24. Reich HJ, Chan JL, Czer LS, Mirocha J, Annamalai AA, Cheng W, Jordan SC, Chaux G, Ramzy D. Combined Lung-Kidney Transplantation: An Analysis of the UNOS/OPTN Database. Am Surg. 2015 Oct; 81(10):1047-52. PMID: 26463306.
      View in: PubMed
    25. Jordan SC. Donor-Specific HLA Antibody IgG Subclasses Are Associated with Phenotypes of Antibody-Mediated Rejection in Sensitized Renal Allograft Recipients. J Am Soc Nephrol. 2016 Jan; 27(1):6-8. PMID: 26293823; PMCID: PMC4696592 [Available on 01/01/17].
    26. Wongsaroj P, Kahwaji J, Vo A, Jordan SC. Modern approaches to incompatible kidney transplantation. World J Nephrol. 2015 Jul 06; 4(3):354-62. PMID: 26167458; PMCID: PMC4491925.
    27. Vo AA, Sinha A, Haas M, Choi J, Mirocha J, Kahwaji J, Peng A, Villicana R, Jordan SC. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization. Transplantation. 2015 Jul; 99(7):1423-30. PMID: 25606792.
      View in: PubMed
    28. Jordan SC, Choi J, Vo A. Kidney transplantation in highly sensitized patients. Br Med Bull. 2015 Jun; 114(1):113-25. PMID: 25935575.
      View in: PubMed
    29. Vo AA, Zeevi A, Choi J, Cisneros K, Toyoda M, Kahwaji J, Peng A, Villicana R, Puliyanda D, Reinsmoen N, Haas M, Jordan SC. A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients. Transplantation. 2015 Feb; 99(2):299-308. PMID: 25606785.
      View in: PubMed
    30. Jordan SC, Choi J, Vo A. Achieving incompatible transplantation through desensitization: current perspectives and future directions. Immunotherapy. 2015; 7(4):377-98. PMID: 25917629.
      View in: PubMed
    31. Kahwaji J, Choi J, Vo A, Jordan SC. Immunologic and Infectious Complications in Highly Sensitized Patients Post-Kidney Transplantation. Clin Transpl. 2015; 31:265-273. PMID: 28514588.
      View in: PubMed
    32. Jordan SC, Choi J, Vo A. Strategies to Improve Novel Drug Development in Kidney Transplantation Through the Clinical Trials Process. Clin Transpl. 2015; 31:163-172. PMID: 28514578.
      View in: PubMed
    33. Kim I, Wu G, Chai NN, Klein AS, Jordan S. Anti-interleukin 6 receptor antibodies attenuate antibody recall responses in a mouse model of allosensitization. Transplantation. 2014 Dec 27; 98(12):1262-70. PMID: 25286051.
      View in: PubMed
    34. Jordan SC, Vo AA. Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches. Curr Opin Organ Transplant. 2014 Dec; 19(6):591-7. PMID: 25304815.
      View in: PubMed
    35. Suviolahti E, Ge S, Nast CC, Mirocha J, Karasyov A, White M, Jordan SC, Toyoda M. Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejection. Transpl Immunol. 2015 Jan; 32(1):9-17. PMID: 25449536.
      View in: PubMed
    36. Vo AA, Choi J, Cisneros K, Reinsmoen N, Haas M, Ge S, Toyoda M, Kahwaji J, Peng A, Villicana R, Jordan SC. Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients. Transplantation. 2014 Aug 15; 98(3):312-9. PMID: 24770617.
      View in: PubMed
    37. Kahwaji J, Jordan S, Puliyanda D, Toyoda M. The authors' reply. Transplantation. 2014 Jul 27; 98(2):e8-9. PMID: 25022239.
      View in: PubMed
    38. Barbosa D, Kahwaji J, Puliyanda D, Mirocha J, Reinsmoen N, Lai CH, Villicana R, Peng A, Jordan SC, Vo A, Toyoda M. Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab. Transplantation. 2014 Apr 15; 97(7):755-61. PMID: 24686425.
      View in: PubMed
    39. Kahwaji J, Najjar R, Kancherla D, Villicana R, Peng A, Jordan S, Vo A, Haas M. Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab. Clin Transplant. 2014 May; 28(5):546-53. PMID: 24579925.
      View in: PubMed
    40. Shin BH, Ge S, Mirocha J, Karasyov A, Vo A, Jordan SC, Toyoda M. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. Transplantation. 2014 Feb 15; 97(3):294-300. PMID: 24342979.
      View in: PubMed
    41. Vo AA, Petrozzino J, Yeung K, Sinha A, Kahwaji J, Peng A, Villicana R, Mackowiak J, Jordan SC. Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab. Transplantation. 2013 Mar 27; 95(6):852-8. PMID: 23511212.
      View in: PubMed
    42. Jordan SC, Vo A, Lai CH, Reinsmoen N. Defining the benefits of desensitization therapy. Transplantation. 2013 Mar 27; 95(6):e31-2. PMID: 23507651.
      View in: PubMed
    43. Loupy A, Jordan SC. Transplantation: Donor-specific HLA antibodies and renal allograft failure. Nat Rev Nephrol. 2013 Mar; 9(3):130-1. PMID: 23399581.
      View in: PubMed
    44. Jordan SC, Vo AA. Evolving concepts in desensitization. Clin Transpl. 2013; 285-92. PMID: 25095520.
      View in: PubMed
    45. Suviolahti E, Petrosyan A, Mirocha J, Ge S, Karasyov A, Thomas D, Galera O, Lim W, Jimenez AM, Czer LS, Chaux G, De Leon J, Pao A, Jordan SC, Toyoda M. Significant reduction of ATP production in PHA-activated CD4+ cells in 1-day-old blood from transplant patients. Transplantation. 2012 Dec 27; 94(12):1243-9. PMID: 23135604.
      View in: PubMed
    46. Todo T, Wu G, Chai NN, He Y, Martins G, Gupta A, Fair J, Liu NY, Jordan S, Klein A. Anti-CD3e induces splenic B220lo B-cell expansion following anti-CD20 treatment in a mouse model of allosensitization. Int Immunol. 2012 Aug; 24(8):529-38. PMID: 22531063.
      View in: PubMed
    47. Loupy A, Hill GS, Jordan SC. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol. 2012 Apr 17; 8(6):348-57. PMID: 22508180.
      View in: PubMed
    48. Reinsmoen NL, Lai CH, Vo A, Jordan SC. Evolving paradigms for desensitization in managing broadly HLA sensitized transplant candidates. Discov Med. 2012 Apr; 13(71):267-73. PMID: 22541614.
      View in: PubMed
    49. Jordan SC, Reinsmoen N, Lai CH, Vo A. Novel immunotherapeutic approaches to improve rates and outcomes of transplantation in sensitized renal allograft recipients. Discov Med. 2012 Mar; 13(70):235-45. PMID: 22463800.
      View in: PubMed
    50. Jordan SC. Complement fixing donor-specific antibodies and allograft loss. Pediatr Transplant. 2012 Feb; 16(1):1-3. PMID: 22248249.
      View in: PubMed
    51. Kahwaji J, Sinha A, Toyoda M, Ge S, Reinsmoen N, Cao K, Lai CH, Villicana R, Peng A, Jordan S, Vo A. Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin. Clin J Am Soc Nephrol. 2011 Dec; 6(12):2894-900. PMID: 22157713; PMCID: PMC3255382.
    52. Jordan SC, Kahwaji J, Toyoda M, Vo A. B-cell immunotherapeutics: emerging roles in solid organ transplantation. Curr Opin Organ Transplant. 2011 Aug; 16(4):416-24. PMID: 21666479.
      View in: PubMed
    53. Lai CH, Cao K, Ong G, Naim M, Wang Q, Mirocha J, Vo A, Jordan SC, Reinsmoen NL. Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy. Transplantation. 2011 Jul 15; 92(1):48-53. PMID: 21562450.
      View in: PubMed
    54. Jordan SC, Toyoda M, Vo AA. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation. Expert Rev Clin Immunol. 2011 May; 7(3):341-8. PMID: 21595600.
      View in: PubMed
    55. Reinsmoen NL, Lai CH, Heidecke H, Haas M, Cao K, Ong G, Naim M, Wang Q, Mirocha J, Kahwaji J, Vo AA, Jordan SC, Dragun D. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation. 2010 Dec 27; 90(12):1473-7. PMID: 21030904.
      View in: PubMed
    56. Jordan S. Courage and character, leaders and legends: an interview with Stan Jordan, MD by Linda Ohler. Prog Transplant. 2010 Dec; 20(4):303-4. PMID: 21265281.
      View in: PubMed
    57. Ge S, Pao A, Vo A, Deer N, Karasyov A, Petrosyan A, Kahwaji J, Lukovsky M, Chai NN, Aguiluz A, Mirocha J, Jordan SC, Toyoda M. Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab. Transpl Immunol. 2011 Apr 15; 24(3):142-8. PMID: 21122815.
      View in: PubMed
    58. Sinha A, Nast CC, Hristea I, Vo AA, Jordan SC. Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy. Clin Exp Nephrol. 2011 Feb; 15(1):164-70. PMID: 21107633.
      View in: PubMed
    59. Kahwaji J, Vo AA, Jordan SC. ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation? Expert Rev Clin Immunol. 2010 Nov; 6(6):893-900. PMID: 20979554.
      View in: PubMed
    60. Amet N, Gacad M, Petrosyan A, Pao A, Jordan SC, Toyoda M. In vitro effects of everolimus and intravenous immunoglobulin on cell proliferation and apoptosis induction in the mixed lymphocyte reaction. Transpl Immunol. 2010 Aug; 23(4):170-3. PMID: 20609387.
      View in: PubMed
    61. Toyoda M, Ge S, Pao A, Vo A, Deer N, Aguiluz A, Karasyov A, Jordan SC. Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levels. Transpl Immunol. 2010 Jul; 23(3):133-40. PMID: 20472061.
      View in: PubMed
    62. Vo AA, Peng A, Toyoda M, Kahwaji J, Cao K, Lai CH, Reinsmoen NL, Villicana R, Jordan SC. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation. 2010 May 15; 89(9):1095-102. PMID: 20110854.
      View in: PubMed
    63. Sharma KG, Radha R, Pao A, Amet N, Baden L, Jordan SC, Toyoda M. Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction. Transpl Immunol. 2010 Jul; 23(3):117-20. PMID: 20450974.
      View in: PubMed
    64. Jordan SC, Reinsmoen N, Peng A, Lai CH, Cao K, Villicana R, Toyoda M, Kahwaji J, Vo AA. Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol. 2010 Oct; 25(10):2035-45; quiz 2045-8. PMID: 20077121; PMCID: PMC2923704.
    65. Toyoda M, Pao A, Vo A, Lukovsky M, Radha R, Sado T, Ge S, Reinsmoen N, Chai NN, Baden L, Petrosyan A, Skinner E, Mirocha J, Jordan SC. Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization. Transpl Immunol. 2010 Feb; 22(3-4):121-7. PMID: 19944759.
      View in: PubMed
    66. Kahwaji J, Barker E, Pepkowitz S, Klapper E, Villicana R, Peng A, Chang R, Jordan SC, Vo AA. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients. Clin J Am Soc Nephrol. 2009 Dec; 4(12):1993-7. PMID: 19833910; PMCID: PMC2798878.
    67. Jordan SC, Toyoda M, Vo AA. Intravenous immunoglobulin a natural regulator of immunity and inflammation. Transplantation. 2009 Jul 15; 88(1):1-6. PMID: 19584672.
      View in: PubMed
    68. Sivakumaran P, Vo AA, Villicana R, Peng A, Jordan SC, Pepkowitz SH, Klapper EB. Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts. J Clin Apher. 2009; 24(4):155-60. PMID: 19658162.
      View in: PubMed
    69. Smith JM, Jordan SC. Intravenous immunoglobulin as treatment for BK virus: nephropathy. Pediatr Transplant. 2009 Feb; 13(1):11-3. PMID: 19077139.
      View in: PubMed
    70. Jordan SC, Peng A, Vo AA. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients. Contrib Nephrol. 2009; 162:13-26. PMID: 19001810.
      View in: PubMed
    71. Reinsmoen NL, Lai CH, Vo A, Cao K, Ong G, Naim M, Wang Q, Jordan SC. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation. 2008 Sep 27; 86(6):820-5. PMID: 18813107.
      View in: PubMed
    72. Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, Peng A, Villicana R, Jordan SC. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med. 2008 Jul 17; 359(3):242-51. PMID: 18635429.
      View in: PubMed
    73. Goland S, Czer LS, Siegel RJ, Tabak S, Jordan S, Luthringer D, Mirocha J, Coleman B, Kass RM, Trento A. Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature. Can J Cardiol. 2008 Jul; 24(7):571-4. PMID: 18612500; PMCID: PMC2640335.
    74. Wu GD, He Y, Chai NN, Toyoda M, Dunn R, Kehry MR, Klein AS, Jordan SC. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization. Transpl Immunol. 2008 Jul; 19(3-4):178-86. PMID: 18595710.
      View in: PubMed
    75. Toyoda M, Moudgil A, Warady BA, Puliyanda DP, Jordan SC. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients. Pediatr Transplant. 2008 Nov; 12(7):778-84. PMID: 18331541.
      View in: PubMed
    76. Puliyanda DP, Toyoda M, Traum AZ, Flores FX, Jordan S, Moudgil A, Somers MJ. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients. Pediatr Transplant. 2008 Mar; 12(2):180-6. PMID: 18307666.
      View in: PubMed
    77. Wechsler E, Yang T, Jordan SC, Vo A, Nast CC. Anti-glomerular basement membrane disease in an HIV-infected patient. Nat Clin Pract Nephrol. 2008 Mar; 4(3):167-71. PMID: 18212779.
      View in: PubMed
    78. Yang T, Nast CC, Vo A, Jordan SC. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant. 2008 Jan; 23(1):377-80. PMID: 17981884.
      View in: PubMed
    79. Bloom BJ, Toyoda M, Petrosian A, Jordan S. Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis. Rheumatol Int. 2007 May; 27(7):655-60. PMID: 17165085.
      View in: PubMed
    80. Puliyanda DP, Amet N, Dhawan A, Hilo L, Radha RK, Bunnapradist S, Czer L, Martin P, Jordan S, Toyoda M. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy. Clin Transplant. 2006 May-Jun; 20(3):289-94. PMID: 16824143.
      View in: PubMed
    81. Vo AA, Cam V, Toyoda M, Puliyanda DP, Lukovsky M, Bunnapradist S, Peng A, Yang K, Jordan SC. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience. Clin J Am Soc Nephrol. 2006 Jul; 1(4):844-52. PMID: 17699296.
      View in: PubMed
    82. Okada Y, Zuo XJ, Toyoda M, Marchevsky A, Matloff JM, Oishi H, Kondo T, Jordan SC. Adenovirus mediated IL-10 gene transfer to the airway of the rat lung for prevention of lung allograft rejection. Transpl Immunol. 2006 Aug; 16(2):95-8. PMID: 16860711.
      View in: PubMed
    83. Jordan SC, Pescovitz MD. Presensitization: the problem and its management. Clin J Am Soc Nephrol. 2006 May; 1(3):421-32. PMID: 17699241.
      View in: PubMed
    84. Jordan SC, Vo A, Tyan D, Toyota M. Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation. Trans Am Clin Climatol Assoc. 2006; 117:199-211; discussion 211. PMID: 18528474; PMCID: PMC1500934.
    85. Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu YM, Katz SM, Akalin E, Esterl R, Gugliuzza K, Shihab F, Jordan S, Jonsson J, Molmenti E, Barbeito R. A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients. Transplantation. 2005 Oct 15; 80(7):910-6. PMID: 16249738.
      View in: PubMed
    86. Toyoda M, Puliyanda DP, Amet N, Baden L, Cam V, Radha R, Pao A, Vo A, Bunnapradist S, Moudgil A, Jordan SC. Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients. Transplantation. 2005 Jul 27; 80(2):198-205. PMID: 16041264.
      View in: PubMed
    87. Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M. Current approaches to treatment of antibody-mediated rejection. Pediatr Transplant. 2005 Jun; 9(3):408-15. PMID: 15910400.
      View in: PubMed
    88. Jordan SC, Vo AA, Toyoda M, Tyan D, Nast CC. Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection. Pediatr Transplant. 2005 Apr; 9(2):155-61. PMID: 15787786.
      View in: PubMed
    89. Ingle GR, Moudgil A, Vo A, Jordan SC. Cyclosporine-sparing effects of daclizumab in renal allograft recipients. Am J Health Syst Pharm. 2005 Feb 15; 62(4):391-6. PMID: 15745891.
      View in: PubMed
    90. Radha R, Jordan S, Puliyanda D, Bunnapradist S, Petrosyan A, Amet N, Toyoda M. Cellular immune responses to cytomegalovirus in renal transplant recipients. Am J Transplant. 2005 Jan; 5(1):110-7. PMID: 15636618.
      View in: PubMed
    91. Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol. 2004 Dec; 15(12):3256-62. PMID: 15579530.
      View in: PubMed
    92. Toyoda M, Petrosyan A, Pao A, Jordan SC. Immunomodulatory effects of combination of pooled human gammaglobulin and rapamycin on cell proliferation and apoptosis in the mixed lymphocyte reaction. Transplantation. 2004 Oct 27; 78(8):1134-8. PMID: 15502709.
      View in: PubMed
    93. Montgomery RA, Hardy MA, Jordan SC, Racusen LC, Ratner LE, Tyan DB, Zachary AA. Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation. 2004 Jul 27; 78(2):181-5. PMID: 15280674.
      View in: PubMed
    94. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan D, Delmonico FL. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004 Jul; 4(7):1033-41. PMID: 15196059.
      View in: PubMed
    95. Puliyanda DP, Wilcox WR, Bunnapradist S, Nast CC, Jordan SC. Fabry disease in a renal allograft. Am J Transplant. 2003 Aug; 3(8):1030-2. PMID: 12859541.
      View in: PubMed
    96. Fong TL, Bunnapradist S, Jordan SC, Selby RR, Cho YW. Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation. 2003 Jul 27; 76(2):348-53. PMID: 12883191.
      View in: PubMed
    97. Jordan S, Cunningham-Rundles C, McEwan R. Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications. Am J Transplant. 2003 Jun; 3(6):653-64. PMID: 12780556.
      View in: PubMed
    98. Bunnapradist S, Gritsch HA, Peng A, Jordan SC, Cho YW. Dual kidneys from marginal adult donors as a source for cadaveric renal transplantation in the United States. J Am Soc Nephrol. 2003 Apr; 14(4):1031-6. PMID: 12660338.
      View in: PubMed
    99. Toyoda M, Pao A, Petrosian A, Jordan SC. Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells. Am J Transplant. 2003 Feb; 3(2):156-66. PMID: 12603211.
      View in: PubMed
    100. Jordan SC, Vo AA, Nast CC, Tyan D. Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience. Clin Transpl. 2003; 193-8. PMID: 15387111.
      View in: PubMed
    101. Bunnapradist S, Vo A, Toyoda M, Alsabeh R, Lockhart C, Puliyanda D, Jordan SC. Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation. Transplantation. 2002 Dec 15; 74(11):1648-51. PMID: 12490805.
      View in: PubMed
    102. Jordan SC. Management of the highly HLA- sensitized patient. A novel role for intravenous gammaglobulin. Am J Transplant. 2002 Sep; 2(8):691-2. PMID: 12243488.
      View in: PubMed
    103. Jordan SC, Vo A, Bunnapradist S, Toyoda M, Kamil E. Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction. Am J Transplant. 2002 Aug; 2(7):671-3. PMID: 12201370.
      View in: PubMed
    104. Barsoum NR, Bunnapradist S, Mougdil A, Toyoda M, Vo A, Jordan SC. Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence. Am J Transplant. 2002 May; 2(5):425-8. PMID: 12123207.
      View in: PubMed
    105. Fong TL, Bunnapradist S, Jordan SC, Cho YW. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999. Transplantation. 2002 Jan 15; 73(1):85-9. PMID: 11792984.
      View in: PubMed
    106. Jordan SC, Quartel AW, Czer LS, Admon D, Chen G, Fishbein MC, Schwieger J, Steiner RW, Davis C, Tyan DB. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation. 1998 Sep 27; 66(6):800-5. PMID: 9771846.
      View in: PubMed
    107. Jordan SC, Tyan D, Czer L, Toyoda M. Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients. Pediatr Transplant. 1998 May; 2(2):92-105. PMID: 10082441.
      View in: PubMed